logo-loader
NYSEMKT:VNRX

VolitionRx

Market:
NYSEMKT
Market Cap:
$189.85 m
Price
4.58 USD
Change
-7.29%
52 weeks high
6.83
52 weeks low
1.67

In brief

Volition is a multi-national life sciences company developing simple, easy to use blood-based cancer tests to accurately diagnose a range of cancers. The tests are based on the science of Nucleosomics®, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid -- an indication that disease is present.

 

Snapshot

Nu.Q test screens for colorectal and prostate cancers, and may have the potential to detect ovarian disease endometriosis